HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 564 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,720,542 | +23.4% | 14,872 | +9.7% | 0.52% | +30.2% |
| Q2 2023 | $1,393,823 | -5.9% | 13,552 | -0.2% | 0.40% | -13.7% |
| Q1 2023 | $1,481,466 | -19.5% | 13,574 | -16.1% | 0.46% | -32.4% |
| Q4 2022 | $1,840,487 | +119.9% | 16,173 | +19.5% | 0.68% | +109.9% |
| Q3 2022 | $837,000 | -18.2% | 13,529 | +5.5% | 0.32% | -16.1% |
| Q2 2022 | $1,023,000 | -32.0% | 12,829 | -3.5% | 0.39% | -21.7% |
| Q1 2022 | $1,505,000 | +21.1% | 13,299 | -0.1% | 0.49% | +21.7% |
| Q4 2021 | $1,243,000 | -9.9% | 13,317 | +13.3% | 0.40% | -1.5% |
| Q3 2021 | $1,380,000 | +4.5% | 11,752 | -5.0% | 0.41% | +0.2% |
| Q2 2021 | $1,321,000 | +28.4% | 12,374 | +9.1% | 0.41% | +20.6% |
| Q1 2021 | $1,029,000 | +74.4% | 11,344 | +38.0% | 0.34% | +36.0% |
| Q4 2020 | $590,000 | – | 8,220 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |